These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 19567243)

  • 21. Closing and Opening Holes in the Glycan Shield of HIV-1 Envelope Glycoprotein SOSIP Trimers Can Redirect the Neutralizing Antibody Response to the Newly Unmasked Epitopes.
    Ringe RP; Pugach P; Cottrell CA; LaBranche CC; Seabright GE; Ketas TJ; Ozorowski G; Kumar S; Schorcht A; van Gils MJ; Crispin M; Montefiori DC; Wilson IA; Ward AB; Sanders RW; Klasse PJ; Moore JP
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity.
    Hu JK; Crampton JC; Cupo A; Ketas T; van Gils MJ; Sliepen K; de Taeye SW; Sok D; Ozorowski G; Deresa I; Stanfield R; Ward AB; Burton DR; Klasse PJ; Sanders RW; Moore JP; Crotty S
    J Virol; 2015 Oct; 89(20):10383-98. PubMed ID: 26246566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a stable HIV-1 B/C recombinant, soluble, and trimeric envelope glycoprotein (Env) highly resistant to CD4-induced conformational changes.
    Kumar R; Ozorowski G; Kumar V; Holden LG; Shrivastava T; Patil S; Deshpande S; Ward AB; Bhattacharya J
    J Biol Chem; 2017 Sep; 292(38):15849-15858. PubMed ID: 28743743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interdomain Stabilization Impairs CD4 Binding and Improves Immunogenicity of the HIV-1 Envelope Trimer.
    Zhang P; Gorman J; Geng H; Liu Q; Lin Y; Tsybovsky Y; Go EP; Dey B; Andine T; Kwon A; Patel M; Gururani D; Uddin F; Guzzo C; Cimbro R; Miao H; McKee K; Chuang GY; Martin L; Sironi F; Malnati MS; Desaire H; Berger EA; Mascola JR; Dolan MA; Kwong PD; Lusso P
    Cell Host Microbe; 2018 Jun; 23(6):832-844.e6. PubMed ID: 29902444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Similarities and differences between native HIV-1 envelope glycoprotein trimers and stabilized soluble trimer mimetics.
    Torrents de la Peña A; Rantalainen K; Cottrell CA; Allen JD; van Gils MJ; Torres JL; Crispin M; Sanders RW; Ward AB
    PLoS Pathog; 2019 Jul; 15(7):e1007920. PubMed ID: 31306470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation.
    Ringe RP; Sanders RW; Yasmeen A; Kim HJ; Lee JH; Cupo A; Korzun J; Derking R; van Montfort T; Julien JP; Wilson IA; Klasse PJ; Ward AB; Moore JP
    Proc Natl Acad Sci U S A; 2013 Nov; 110(45):18256-61. PubMed ID: 24145402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SOSIP Changes Affect Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Conformation and CD4 Engagement.
    Alsahafi N; Anand SP; Castillo-Menendez L; Verly MM; Medjahed H; Prévost J; Herschhorn A; Richard J; Schön A; Melillo B; Freire E; Smith AB; Sodroski J; Finzi A
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influences on the Design and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers.
    Ringe RP; Yasmeen A; Ozorowski G; Go EP; Pritchard LK; Guttman M; Ketas TA; Cottrell CA; Wilson IA; Sanders RW; Cupo A; Crispin M; Lee KK; Desaire H; Ward AB; Klasse PJ; Moore JP
    J Virol; 2015 Dec; 89(23):12189-210. PubMed ID: 26311893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers.
    Blattner C; Lee JH; Sliepen K; Derking R; Falkowska E; de la Peña AT; Cupo A; Julien JP; van Gils M; Lee PS; Peng W; Paulson JC; Poignard P; Burton DR; Moore JP; Sanders RW; Wilson IA; Ward AB
    Immunity; 2014 May; 40(5):669-80. PubMed ID: 24768348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutralizing Antibody Induction by HIV-1 Envelope Glycoprotein SOSIP Trimers on Iron Oxide Nanoparticles May Be Impaired by Mannose Binding Lectin.
    Ringe RP; Cruz Portillo VM; Dosenovic P; Ketas TJ; Ozorowski G; Nogal B; Perez L; LaBranche CC; Lim J; Francomano E; Wilson IA; Sanders RW; Ward AB; Montefiori DC; Nussenzweig MC; Klasse PJ; Cupo A; Moore JP
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31852794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in Structure and Antigenicity of HIV-1 Env Trimers Resulting from Removal of a Conserved CD4 Binding Site-Proximal Glycan.
    Liang Y; Guttman M; Williams JA; Verkerke H; Alvarado D; Hu SL; Lee KK
    J Virol; 2016 Oct; 90(20):9224-36. PubMed ID: 27489265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
    Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical and biophysical comparison of cleaved and uncleaved soluble, trimeric HIV-1 envelope glycoproteins.
    Dey AK; David KB; Lu M; Moore JP
    Virology; 2009 Mar; 385(1):275-81. PubMed ID: 19135223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural characterization of cleaved, soluble HIV-1 envelope glycoprotein trimers.
    Khayat R; Lee JH; Julien JP; Cupo A; Klasse PJ; Sanders RW; Moore JP; Wilson IA; Ward AB
    J Virol; 2013 Sep; 87(17):9865-72. PubMed ID: 23824817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Well-ordered trimeric HIV-1 subtype B and C soluble spike mimetics generated by negative selection display native-like properties.
    Guenaga J; de Val N; Tran K; Feng Y; Satchwell K; Ward AB; Wyatt RT
    PLoS Pathog; 2015 Jan; 11(1):e1004570. PubMed ID: 25569572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein.
    Richardson TM; Stryjewski BL; Broder CC; Hoxie JA; Mascola JR; Earl PL; Doms RW
    J Virol; 1996 Feb; 70(2):753-62. PubMed ID: 8551612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Adjuvants on HIV-1 Envelope Glycoprotein SOSIP Trimers
    Ozorowski G; Cupo A; Golabek M; LoPiccolo M; Ketas TA; Cavallary M; Cottrell CA; Klasse PJ; Ward AB; Moore JP
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1.
    Sanders RW; Vesanen M; Schuelke N; Master A; Schiffner L; Kalyanaraman R; Paluch M; Berkhout B; Maddon PJ; Olson WC; Lu M; Moore JP
    J Virol; 2002 Sep; 76(17):8875-89. PubMed ID: 12163607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of Novel Structural Determinants in MW965 Env That Regulate the Neutralization Phenotype and Conformational Masking Potential of Primary HIV-1 Isolates.
    Qualls ZM; Choudhary A; Honnen W; Prattipati R; Robinson JE; Pinter A
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conformational Differences between Functional Human Immunodeficiency Virus Envelope Glycoprotein Trimers and Stabilized Soluble Trimers.
    Castillo-Menendez LR; Nguyen HT; Sodroski J
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.